Nanosphere Will Submit Troponin Assay to FDA This Year, Expand European Launch

Nanosphere said it has completed data collection in a fast track trial toward submitting its cardiac troponin I assay for FDA approval later this year.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.